Liu L Y, Hong W J, Hou Y J, Yao Z H, Wu A R, Li L
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1987 Sep;9(5):375-8.
62 patients with advanced epithelial ovarian adenocarcinoma (37 stage III, 4 stage IV and 22 recurrent lesions) were treated in our hospital from 1977 to 1981, 38 patients underwent surgery. 25 with inoperable tumor initially received preoperative chemotherapy (VCF protocol: vincristine + cyclophosphamide + fluorouracil chiefly) followed by surgery. The response rate of chemotherapy was 48%. Apart from 1 progressive tumor during chemotherapy, 24/25 were explored. There were 10/24 with residual tumor less than 2 cm in diameter, giving a resection rate of 41.7% as compared with the resection rate of 42.1% (16/38) in the operation group. It is shown that the preoperative chemotherapy improves the resection rate. 44 patients received postoperative chemotherapy and 12, radiotherapy combined with chemotherapy or radiotherapy only. The overall 2.3 and 5 year survival rates of these 63 patients were 39.7%, 31.7% and 23.8%. The 2 and 3 year survivals were 41.9% and 32.3% in 31 patients with postoperative chemotherapy using VCF protocol. The results indicate that VCF protocol is effective for advanced epithelial ovarian cancer, especially patients with residual tumor less than 2 cm in size. Chemotherapy with more than 3 courses has better effect.
1977年至1981年期间,我院收治了62例晚期上皮性卵巢腺癌患者(Ⅲ期37例,Ⅳ期4例,复发病灶22例),其中38例行手术治疗。25例初诊时无法手术切除的肿瘤患者先接受术前化疗(主要采用VCF方案:长春新碱+环磷酰胺+氟尿嘧啶),随后接受手术。化疗有效率为48%。除1例化疗期间肿瘤进展外,其余24/25例接受了手术探查。24例中有10例残留肿瘤直径小于2cm,切除率为41.7%,而手术组的切除率为42.1%(16/38)。结果表明,术前化疗可提高切除率。44例患者接受了术后化疗,12例接受了放疗联合化疗或单纯放疗。这63例患者的2年和5年总生存率分别为39.7%、31.7%和23.8%。31例采用VCF方案进行术后化疗的患者,其2年和3年生存率分别为41.9%和32.3%。结果表明,VCF方案对晚期上皮性卵巢癌有效,尤其是对残留肿瘤直径小于2cm的患者。化疗3个疗程以上效果更佳。